Sweden· SE-19760906000013
Rhesonativ 625 IE/ml Injektionsvätska, lösning
A medicinal product containing human anti-d immunoglobulin, registered in Sweden by Octapharma AB.
Checked against Swedish Medical Products Agency (Sweden) on
Informational only — not a medical device.
The record
At a glance
Swedish Medical Products Agency (Sweden)- Active substance
- Human Anti-D Immunoglobulin
- Manufacturer
- Octapharma AB
- Country
- Sweden (SE)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- Swedish Medical Products Agency (Sweden)
- Last checked
- October 1, 2026
Packs & prices · 1
- se_varunummer19760906000013
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Human anti-d immunoglobulin in 16 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaRHESONATIVOctapharma (IP) SPRL, Brusel
- NorwayRhesonativOctapharma AS
- United KingdomAnti-D (RHO) immunoglobulin 1,250units/1ml solution for injection pre-filled syringesBaxter Healthcare Ltd
- FinlandRhesonativOctapharma Ab
- United StatesHYPERRHOGRIFOLS USA, LLC
- NetherlandsRhesonativ 625 IE/ml, oplossing voor injectieOctapharma GmbH
- PolandGamma anty-D 150Synthaverse S.A.
- BelgiumImmunorho 300 µg/2 mlKedrion
Authorised across Europe · EMA
The same active substance is authorised in 28 EEA countries. Names it is sold under:
- Austria · Rhesonativ, Rhophylac
- Belgium · Immunorho, Rhophylac
- Bulgaria · Резонатив
- Cyprus · Rhesonativ, Rhophylac
- Czechia · Igamad, Rhesonativ
- Germany · Rhesonativ, Rhophylac
- Denmark · Rhesonativ, Rhophylac
- Estonia · Rhesonativ
- Spain · Igamad, Rhophylac
- Finland · Rhophylac
- France · Rhesonativ, Rhophylac
- United Kingdom (Northern Ireland) · D-Gam, Rhophylac
- Greece · Rhophylac
- Hungary · Rhesonativ, Rhophylac
- Ireland · Rhophylac
- Iceland · Rhesonativ, Rhophylac
- Italy · Igamad, Immunorho
- Lithuania · Rhesonativ
- Luxembourg · Rhesonativ, Rhophylac
- Latvia · Rhesonativ
- Malta · Rhesonativ, Rhophylac
- Netherlands · Rhesonativ, Rhophylac
- Norway · Rhesonativ, Rhophylac
- Poland · Gamma Anty-D, Rhesonativ
- Portugal · Rhesonativ, Rhophylac
- Romania · Rhesonativ, Rhophylac
- Slovenia · Rhesonativ, Rhophylac
- Slovakia · Igamad, Rhesonativ
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swedish Medical Products Agency (Sweden). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/e3669bc2-31b0-4b49-86b0-ac3a28620b2b GET /v1/drugs/e3669bc2-31b0-4b49-86b0-ac3a28620b2b?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"source": "lakemedelsverket",
"doc_types": [
"SmPC",
"PL",
"PAR"
],
"se_npl_id": "19760906000013",
"product_page": "https://www.lakemedelsverket.se/sv/sok-lakemedelsfakta/lakemedel?id=19760906000013",
"product_doc_link": "https://docetp.mpa.se/LMF/Rhesonativ%20625%20IU%20per%20ml%20solution%20for%20injection%20ENG%20SmPC_09001bee807a752b.pdf"
}See everything about human anti-d immunoglobulin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.